MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Electronic Health Record Review, Interview, Media Intervention, Survey Administration.
- Кому может быть актуально
- Состояния в реестре: Breast Carcinoma. Базовые параметры: 40 лет — 74 лет · Женщины.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Implementing USPSTF Recommendations for Breast Cancer Screening and Prevention by Integrating Clinical Decision Support Tools With the Electronic Health Record
Обзор
This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.
Подробное описание
PRIMARY OBJECTIVES:
I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.
II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).
SECONDARY OUTCOMES:
I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.
OUTLINE:
CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will undergo training sessions of about 20 minutes, then participate in interviews lasting up to 30 minutes at baseline prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase about six months after the last reminders are sent.
PATIENTS: Patients (enrolled from OHSU IMC) participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.
Вмешательства
- Другое Electronic Health Record Review
Health record reviewed - Другое Interview
Participate in interview - Другое Media Intervention
Use MammoScreen - Другое Survey Administration
Complete survey - Другое Training and Education
Undergo training
Первичные конечные точки
- Uptake of MammoScreen [Срок оценки: Up to 5 years]
- Number of women with above-average risk for breast cancer identified by MammoScreen integrated with the electronic health record [Срок оценки: Up to 5 years]
Вторичные конечные точки (6)
- Rates of mammography screening referral [Срок оценки: Up to 5 years]
- Screening completed [Срок оценки: Up to 5 years]
- Mammography results [Срок оценки: Up to 5 years]
- Number of above average risk MammoScreen users who received a genetic counseling referral [Срок оценки: Up to 5 years]
- Number of above average risk MammoScreen users who completed a genetic counseling visit [Срок оценки: Up to 5 years]
- Number of above average risk MammoScreen users who had a genetic test done [Срок оценки: Up to 5 years]
Критерии участия
Критерии включения
- Women between the ages of 40 and 74
- Enrolled in MyChart
- Able to read English
Критерии исключения
- Personal history of breast or ovarian cancer
- Currently Pregnant
- Currently in Hospice
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Модель наблюдения
- Другое
Центры проведения
США · 1 центр
- OHSU Knight Cancer Institute — Portland
Идентификаторы
NCT: NCT04996316 · STUDY00022698 · NCI-2021-06583 · STUDY00022698 · R01HS027796